Results

Total Results: 2,166 records

Showing results for "event".

141. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - inhibitors, and considerations for restarting anticoagulation therapy in patients after a hemorrhagic event … therapy or performing a procedural intervention as a stroke prevention strategy following a hemorrhagic event … heart failure, coronary artery disease, and high cholesterol); patients with prior stroke (by type of event … Page 7 o KQ 6: Other strategies for resuming anticoagulation therapy following a hemorrhagic event … failure, coronary artery disease, and high cholesterol) o Patients with prior stroke (by type of event

142. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/disruptive-behavior/research
     April 01, 2025 - placebo, but pharmacotherapy was associated with a small increase in the risk of experiencing any adverse event … The use of medications was associated with an increased risk of experiencing any adverse event, but serious

143. Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/urinary-incontinence-update/final-report-2018
     July 01, 2020 - Quality of life and adverse event outcomes are narratively described. Results. … Dry mouth was the most commonly reported adverse event for the anticholinergic oxybutynin (36%) and the

144. Making Healthcare Safer IV_Rapid Response: Patient and Family Engagement (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-patient-family-engagement.pdf
     October 01, 2023 - Patient and family engagement in safety event reporting using patient-reported measures is an emerging … *"[tiab] OR "undesired event*"[tiab] OR "medical errors"[mh] OR "medical error*"[tiab] OR "Diagnostic … *"[Title/Abstract] OR "undesired event*"[Title/Abstract] OR "medical errors"[MeSH Terms] OR "medical … *" OR "undesired event*" OR "medical error*" OR "diagnostic error*" OR "diagnostic mistake*" OR "health … *" OR "undesired event*" OR "medical error*" OR "diagnostic error*" OR "diagnostic mistake*" OR "health

145. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - or withdrawal due to any adverse event did not reach statistical significance). … Meloxicam was also associated with decreased risk of any adverse event (RR 0.91, 95% CI 0.84 to 0.99) … Etodolac was associated with lower risk of any adverse event compared to nonselective NSAIDs (RR 0.83 … However, because the event rates increases in older patients, even if the relative risk estimates are … the same, the absolute event rates are higher.

146. Comparative Effectiveness of Physical Therapy for Knee Pain Secondary to Osteoarthritis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/arthritis-knee-physical-therapy/research-protocol
     December 01, 2019 - report the results from random effects models only. 45 The number needed to treat to achieve one event … rate – treatment group event rate). … of avoided or excess events (respectively) per population of 1000 is the difference between the two event … rates multiplied by 1000: (control group event rate – treatment group event rate)*1000. … Analogue Scale WOMAC Western Ontario McMaster Summary of Protocol Amendments In the event

147. Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
     January 01, 2024 - low density lipoprotein cholesterol (LDL-c) concentration, and between LDL-c concentration and CV event … and evidence-based guidance to optimize plasma lipoprotein profiles, with the goal of lowering CV event … We will aim for a minimum of about 10 observational studies for each specific intervention - CV event … acids and cardiovascular disease (https://doi.org/10.23970/AHRQEPCERTA223), we included: for cardiac event

148. Disposition of comments_Comparative Effectiveness Review No. 244: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
     May 25, 2021 - We agree that the timing of each adverse event relates to the vaccine and particular adverse event. … However, such detail at a study level or even vaccine/adverse event level would make the report even … "Reported in" means that there was documentation of the presence or absence of the event. … adverse event) is missing. … We have removed the wording about FDA review of this event as it was not specifically commented on

149. Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
     January 01, 2024 - characteristics have important biological implications in terms of plasma lipoprotein profiles and subsequent CV event … and evidence-based guidance to optimize plasma lipoprotein profiles, with the goal of lowering CV event … prospectively  We will aim for a minimum of about 10 observational studies for each specific PUFA - CV event … acids and cardiovascular disease (https://doi.org/10.23970/AHRQEPCERTA223), we included: for cardiac event

150. Comparative Effectiveness Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - 1/00 and 11/30/01; patients who changed medicines were included in both groups Duration to event … in patients taking low-dose aspirin and time-to-event of other GI events including 1) complicated … Cumulative 12-wk incidence of any moderate to severe upper GI AE based on Kaplan-Meier time-to- event … Lumiracoxib compared less favorably with naproxen (0.37% event rate with lumiracoxib v 0.22% event rate … COX-2 vs NSAID: Overall RR of any vascular event among heterogeneous studies 1.0%/yr vs 0.9%/yr was

151. Cannabis-2024-Surv-Rep-Update-Table-Appendix-E (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2024-surv-rep-update-table-appendix-e.xlsx
     January 01, 2024 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … error SF-36 Short-form 36 Question Survey THC tetrahydrocannabinol TRAE treatment related adverse event

152. Cer-250-Cannabis-2024-Surv-Rep-Update-Table-E5 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
     January 01, 2024 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … error SF-36 Short-form 36 Question Survey THC tetrahydrocannabinol TRAE treatment related adverse event

153. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
     September 01, 2009 - stroke (hemorrhagic, ischemic, or unspecified), transient ischemic attack, unspecified cerebrovascular event … cancer, treatment adherence, withdrawal due to adverse events, participants with at least one adverse event … Overall, 5 percent of participants had an event. … Compared with statin monotherapy, more participants developed at least one adverse event with statin-BAS … Nevertheless, all-cause mortality was a rare event across most trials. Followup duration.

154. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
     July 01, 2009 - There were 84 studies that reported at least one adverse event associated with RFA. … 0 percent to 5 percent (median 1 percent) of patients in the 70 studies that reported this adverse event … Atrioesophageal fistula was reported in 26 studies: 5 studies reported 1 case each, with event rates … RFA monitoring and use modalities that are more sensitive to asymptomatic recurrences of AF (e.g., event … All studies should actively collect adverse event data from study participants.

155. CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
     May 01, 2021 - and that the findings of the studies did not constitute evidence of increased risk of the adverse event … and that the findings of the studies did not constitute evidence of increased risk of the adverse event … and that the findings of the studies did not constitute evidence of increased risk of the adverse event … when determining whether studies are warranted, including the severity and frequency of the adverse event

156. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-risk Preschoolers; Long-term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/adhd/research-protocol
     December 01, 2019 - < 6 years of age with ADHD or Disruptive Behavior Disorder, what are the effectiveness and adverse event … Among people 6 years of age or older with ADHD, what are the effectiveness and adverse event outcomes … Statistics Outcomes Numerical or statistical results of any effectiveness or adverse event … outcomes Numerical or statistical results of any effectiveness or adverse event outcomes

157. A total of 1,364 patients were treated with a neurothrombectomy device as part of X reports (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
     July 01, 2014 - Naming of proxy decisionmaker Preferences for emergency management of acute life threatening event … Preferences for ongoing management of chronic illness in event of loss of decisional capacity, … Role definition for proxy, criteria to consider proxy appropriateness Probability of adverse event … proximity to need for clinical decision Healthy End of life Life threatening Illness or event … Potentially life threatening illness Hospice or frail elderly Life threatening Illness or event

158. Appendix-E-Table-E5 0 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
     November 04, 2021 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

159. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
     February 16, 2022 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

160. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
     August 10, 2010 - < 6 years of age with ADHD or Disruptive Behavior Disorder, what are the effectiveness and adverse event … Among people 6 years of age or older with ADHD, what are the effectiveness and adverse event outcomes … Descriptive Statistics Outcomes  Numerical or statistical results of any effectiveness or adverse event … outcomes  Numerical or statistical results of any effectiveness or adverse event outcomes 